Ellomay Capital Ltd.

Foreign Filer Report • Nov 1, 2017

UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2017 Commission File Number: 001-35284

Ellomay Capital Ltd.

(Translation of registrant's name into English)

9 Rothschild Blvd., Tel Aviv 6688112, Israel(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐No ☒

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________ This Report on Form 6-K of Ellomay Capital Ltd. consists of the following document, which is attached hereto and incorporated by reference herein:

Exhibit 99.1November 2017 Investor Presentation

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Ellomay Capital Ltd.

By: /s/ Ran Fridrich

Ran Fridrich Chief Executive Officer and Director

Dated: November 1, 2017

Disclaimer

General:

• • The information contained in this presentation is subject to, and must be read in conjunction with, all other publically available information, including our Annual Report on Form 20-F for the year ended December 31, 2016, and other filings that we make from time to time with the SEC. Any person at any time acquiring securities must do so only on the basis of such person's own judgment as to the merits or the suitability of the securities for its purpose and only based on such information as is contained in such public filings, after having taken all such professional or other advice as it considers necessary or appropriate in the circumstances and not in reliance on the information contained in the presentation. In making this presentation available, we give no advice and make no recommendation to buy, sell or otherwise deal in our shares or in any other securities or investments whatsoever. We do not warrant that the information is either complete or accurate, nor will we bear any liability for any damage or losses that may result from any use of the information.
• • Neither this presentation nor any of the information contained herein constitute an offer to sell or the solicitation of an offer to buy any securities. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. No offering of securities shall be made in Israel except pursuant to an effective prospectus under the Israeli Securities Law, 1968 or an exemption from the prospectus requirements under such law.
• •Historical facts and past operating results are not intended to mean that future performances or results for any period will necessarily match or exceed those of any prior year.
• • This presentation and the information contained herein are the sole property of the company and cannot be published, circulated or otherwise used in any way without our express prior written consent.

Information Relating to Forward-Looking Statements:

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this presentation regarding our plans and the objectives of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Israeli Securities Law, 1968. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by our forward-looking statements, including weather conditions, regulatory changes, changes in the supply and prices of resources required for the operation of our facilities (such as waste and natural gas), changes in demand and technical and other disruptions in the operations or construction of the power plants owned by us. These and other risks and uncertainties associated with our business are described in greater detail in the filings we make from time to time with SEC, including our Annual Report on Form 20-F. The forward-looking statements are made as of this date and we do not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Forecasted Cash Flow from Projects 2018

November 1, 2017

Website: www.ellomay.com NYSE American: ELLO

Estimated 2018 CF Projection from Projects, (US\$ in million)

	Italy and Spain	Talmei Yosef,	Waste to	Waste to
	PV	Israel 9 MW PV	Energy NL	Energy NL	US \$ in millions
			GGG 1.1.2018-	GGOT 1.4.18-
			31.12.2018	31.12.2018
Projects income	14.4	4.6	4.1	3	26.1
Operating Costs and G&A of projects	-2.8	-0.6	-2.1	-1.8	-7.3
Financing Expenses, Net	-0.7	-1.2	-0.1	-0.1	-2.1
Tax Expenses	-1.3	0.0	-0.2	0.0	-1.5
Net expected CF from projects	9.6	2.8	1.7	1.1	15.2
Principal payments (project finance)	-1.4	-1.7	-0.6	-0.3	-4.0
Net expected CF from projects after debt service	8.2	1.1	1.1	0.8	11.2
Minority rights	0	0	-0.5	-0.4	-0.9
Ellomay's share of net expected CF from projects	8.2	1.1	0.56	0.41	10.3
Ellomay's expected CF from Dorad					P
Total 2018 estimated CF from projects *					12.3

Based on the following FX rates: NIS/EUR – NIS/USD –3.51; USD/EUR – 1.181

4

* The CF presented in the table is presented on a per project basis and does not include corporate expenses and Series A and Series B debentures related expenses.

2017 Vs. 2018 (US\$ in million)

	2017 (US \$ in 2018 (US \$ in millions)	millions)
Estimated income from projects	14.4	26.1
Total estimated CF from projects *	9.5	12.3

Based on the following FX rates: NIS/EUR – NIS/USD –3.51; USD/EUR – 1.181

* The CF presented in the table is presented on a per project basis and does not include corporate expenses and Series A and Series B debentures related expenses.

Production Chain of a Biogas Facility

The Goor Project

* Goor Site

* Inside a digester

* Upgrading Room

* Upgrading Room

The construction of the project is advancing as planned (completion expected during November 2017)

The Goor Project – General Details

The Goor Project is the first project out of the biogas projects planned in connection with the cooperation with Ludan

Expected Annual Facility Output

9

Manufacturing Hours – Approx. 8,000 hours (8,766 hours X efficiency rate of 91%)

• Gas Manufacturing Scope – 3 million M³
• Electricity Manufacturing Scope – 5.6 million KWH
• Heat Manufacturing Scope – 10,800 GJ

Supplied to the national electricity grid

For internal use as part of the gas purification process

Construction of the Facility

• Expected construction cost (CAPEX) – Approx. Euro 9.7 million
• Expected construction duration – Approx. one year
• Status – facility testing stage, take over planned for mid November 2017

The Goor Project – Main Agreements

Financing Agreement

• Feedstock Agreement
• Off-take Agreements – sale of gas, electricity and green certificates

The Goor Project – Financing Agreement

Principles of the Agreement:

• Financing Bank – Coöperatieve Rabobank U.A.
• Scope of Senior Debt – Euro 5.6 million for 12 years (A and B Facilities)

• LTC of approx. 60%

• Fixed annual interest for 5 years of 3% (Facility A) and 2.5% (Facility B – Green Loan)

• Equity / shareholders loans – Approx. Euro 4.1 million1

1. Ellomay's portion of the equity is 51%

The Goor Project – Feedstock Agreement

Principles of the Agreement:

• Supplier – Oude Lenferink
• Supplying all of the waste required in order to operate the facility
• "Gate Fee" price – payment from the supplier to the project for receiving the waste (as the facility provides the supplier with a waste disposal solution)
• Other waste price – payment to the supplier for providing other types of waste that the facility requires
• Payment for removal of the digestate from the facility

The Goor Project – Off take Agreements

The Goor Project - Regulation

The Involvement of the Company in the Project

Ellomay Capital's Purchase of Talasol

• • On April 2017 Ellomay entered, through one of the its subsidiaries, into a share purchase agreement (the "SPA") pursuant to which it purchased and acquired the entire share capital of a Spanish company, Talasol Solar S.L. ("Talasol"), that is promoting the development and construction of a photovoltaic plant with a peak capacity of 300 MWin the municipality of Talaván, Cáceres, Spain (the "Project ").
• • The SPA provides that the purchase price for Talasol's shares is Euro 10 million (approximately \$10.9 million), payment of which is subject to the non-occurrence of customary conditions subsequent in these type of transactions. From the total amount of the purchase price, an amount of Euro 2 million (approximately \$2.18 million) will be retained and withheld by Ellomay until the earlier of the commissioning of the Project or the third anniversary of the SPA.
• • The SPA includes customary representations and warranties. The SPA includes several conditions subsequent, the occurrence of any of which by June 30, 2018 will allow Ellomay to automatically terminate the SPA. These conditions include receipt of certain regulatory approvals and entry into certain material agreements with third parties. The SPA further provides the sellers with rights to terminate the SPA in the event the regulatory approvals are granted and Ellomay or Talasol fail to take certain actions requiredin order to advance the Project.

Agreements, Permits, Authorizations and Licenses - Status

Estimated Project's Key Milestones

• (1) Submission of RFP documents. Bids submission expected in the beginning of Q1 2018, and closing of the EPC contract expected by financial close.
• (2)COD will be finally determined during Q2-Q3 2018, when the construction contract with REE is expected to signed.

Initial Estimation of Key Economic Parameters

• (1) Based on an initial study performed by Ellomay's technical advisors, the Project's CAPEX including development costs (approximately Euro 20 million) and interest (approximately Euro 7 million) is expected to be approximately Euro 200 million, depending on the terms of the EPC agreement that will be executed in connection with the Project and other factors. Tendering the EPC contract isexpected to reduce the EPC costs.
• (2) The Project is expected to produce approximately 565GWh per year, and based on the "base case" scenario of a prices projection study is expected to yield revenues of approximately Euro 20-25 million per year. Talasol is negotiating long-term off take agreements with a short list of reputable off-takers with at least an investment grade credit rating.
• (3) Ellomay expects that the Project's operating and G&A expenses will amount to an aggregate of approximately Euro 6 million and, therefore, revenues net of such expenses are currently expected to be approximately Euro 19 million per year.

20 20

Thank You